Home >> Marketplace Archives >> FDA clears test to detect antibodies to HMGCR

FDA clears test to detect antibodies to HMGCR

Print Friendly, PDF & Email

September 2018—Inova Diagnostics announced FDA clearance of its Quanta Flash HMGCR for use on its Bio-Flash random access chemiluminescent system. Quanta Flash HMGCR is a semiquantitative chemiluminescence immunoassay for the determination of IgG autoantibodies against HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase) antigen in human serum. The presence of anti-HMGCR antibodies, in conjunction with clinical findings and other laboratory tests, is an aid in the diagnosis of idiopathic inflammatory myopathy.

Inova Diagnostics, 858-586-9900

x

Check Also

FDA-cleared Inova Dx calprotectin test

Jan. 8, 2018—Inova Diagnostics announced the clearance of Quanta Flash Calprotectin by the FDA. Quanta...

X